Chemoprophylaxis of HIV infection: moving forward with caution.
Grant
Robert M
RM
Wainberg
Mark A
MA
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D018890:Chemoprevention; D004195:Disease Models, Animal; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D008253:Macaca mulatta; D063065:Organophosphonates / Q000627:therapeutic use*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000187:drug effects; D000068698:Tenofovir
D000998:Antiviral Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine